PPMI, Effort to Better Understand Parkinson’s, Enrolling Adults
The Parkinson’s Progression Markers Initiative (PPMI) is expanding to enroll up to 100,000 people with and without Parkinson’s disease…
Articles by Marisa Wexler, MS
Osteoarthritis Linked With Higher Risk of Parkinson’s in 2 Studies
People with the most common form of arthritis, osteoarthritis, may be at increased risk of developing Parkinson’s disease, according to…
Nordic Walking Can Help Patients in Gaining More Efficient Gait
Because people with Parkinson’s disease tend to take shorter steps and move more slowly, they get less of a…
Age at Disease Onset Results in Distinct Speech Patterns
People with early- or late-onset Parkinson’s disease tend to have different characteristic changes in their speech, according to a…
Mitochondrial Dysfunction Enough to Cause Parkinson’s in Mice
Mitochondrial dysfunction in dopamine-producing brain cells is sufficient to cause Parkinson’s disease, according to a new study done in…
CST-103 Improves Brain Blood Flow in Early Clinical Trial
Treatment with the investigational therapy CST-103 increased blood flow to certain regions of the brains of people with Parkinson’s…
Probiotic Solace PS128 Eases ‘Off’ Periods, Motor Symptoms in Trial
The active agent in Solace PS128, a probiotic sold by Oryx Biomedical, eased disease symptoms and improved life…
Longer ‘On’ Time Seen With Infused ABBV-951 Than Oral Levodopa in Trial
ABBV-951, an under-the-skin formulation of levodopa/carbidopa, outperformed the standard oral therapy at controlling Parkinson’s symptoms in advanced disease patients…
Studies Into How Alpha-synuclein Affects Key Immune Cell Needed
More research is needed to understand how alpha-synuclein — a protein whose accumulation is characteristic of Parkinson’s disease —…
Low Levels of Vitamin B6 and B12 Linked to Patients’ Nerve Damage
Neuropathy, or nerve damage, was linked to abnormally low levels of the vitamins B6 and B12 in three people with…